78 related articles for article (PubMed ID: 2773647)
21. Cerebral delta opioid receptors mediate analgesia but not the intestinal motility effects of intracerebroventricularly administered opioids.
Galligan JJ; Mosberg HI; Hurst R; Hruby VJ; Burks TF
J Pharmacol Exp Ther; 1984 Jun; 229(3):641-8. PubMed ID: 6327967
[TBL] [Abstract][Full Text] [Related]
22. Six highly active mu-selective opioid peptides identified from two synthetic combinatorial libraries.
Dooley CT; Kaplan RA; Chung NN; Schiller PW; Bidlack JM; Houghten RA
Pept Res; 1995; 8(3):124-37. PubMed ID: 7670227
[TBL] [Abstract][Full Text] [Related]
23. Synthesis of N alpha-, and C alpha-derivatives of (D)Ala2, Leu5-enkephalin.
Filippi B; Biondi L; Filira F; Rocchi R
Farmaco Sci; 1983 Oct; 38(10):713-24. PubMed ID: 6641923
[TBL] [Abstract][Full Text] [Related]
24. Preparation and opioid activities of N-methylated analogs of [D-Ala2,Leu5]enkephalin.
Kawai M; Fukuta N; Ito N; Kagami T; Butsugan Y; Maruyama M; Kudo Y
Int J Pept Protein Res; 1990 May; 35(5):452-9. PubMed ID: 2165469
[TBL] [Abstract][Full Text] [Related]
25. Synthesis, opioid receptor binding, and biological activities of naltrexone-derived pyrido- and pyrimidomorphinans.
Ananthan S; Kezar HS; Carter RL; Saini SK; Rice KC; Wells JL; Davis P; Xu H; Dersch CM; Bilsky EJ; Porreca F; Rothman RB
J Med Chem; 1999 Sep; 42(18):3527-38. PubMed ID: 10479286
[TBL] [Abstract][Full Text] [Related]
26. Tolerance and cross-tolerance to the antisecretory effects of enkephalins on the guinea-pig ileal mucosa.
Vinayek R; Brown DR; Miller RJ
J Pharmacol Exp Ther; 1985 Mar; 232(3):781-5. PubMed ID: 2983070
[TBL] [Abstract][Full Text] [Related]
27. Behavioral effects of opioid peptides selective for mu or delta receptors. I. Morphine-like discriminative stimulus effects.
Locke KW; Holtzman SG
J Pharmacol Exp Ther; 1986 Sep; 238(3):990-6. PubMed ID: 3018230
[TBL] [Abstract][Full Text] [Related]
28. Modulatory effect of endogenous and exogenous opioids on the excitatory reflex pathway of the rat ileum.
Allescher HD; Storr M; Brechmann C; Hahn A; Schusdziarra V
Neuropeptides; 2000 Feb; 34(1):62-8. PubMed ID: 10688971
[TBL] [Abstract][Full Text] [Related]
29. Functional opiate receptors in the guinea-pig ileum: their differentiation by means of selective tolerance development.
Schulz R; Wüster M; Rubini P; Herz A
J Pharmacol Exp Ther; 1981 Nov; 219(2):547-50. PubMed ID: 6270313
[TBL] [Abstract][Full Text] [Related]
30. Analgesic activity and pharmacological characterization of N-[1-phenylpyrazol-3-yl]-N-[1-(2-phenethyl)-4-piperidyl] propenamide, a new opioid agonist acting peripherally.
Goicoechea C; Sánchez E; Cano C; Jagerovic N; Martín MI
Eur J Pharmacol; 2008 Oct; 595(1-3):22-9. PubMed ID: 18706410
[TBL] [Abstract][Full Text] [Related]
31. The synthesis and pharmacological activity of two new derivatives of benzazocine.
Gutkowska B; Gumułka SW; Krzaścik P; Poppe I; Mészáros J; Makulska HE
Pol J Pharmacol Pharm; 1991; 43(2):153-63. PubMed ID: 1658757
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and biological activity of [Leu5]enkephalin derivatives containing D-glucose.
Horvat J; Horvat S; Lemieux C; Schiller PW
Int J Pept Protein Res; 1988 May; 31(5):499-507. PubMed ID: 2842267
[TBL] [Abstract][Full Text] [Related]
33. Study of the analgesic effects of galanthamine, a cholinesterase inhibitor.
Cozanitis DA; Friedmann T; Fürst S
Arch Int Pharmacodyn Ther; 1983 Dec; 266(2):229-38. PubMed ID: 6667067
[TBL] [Abstract][Full Text] [Related]
34. Stability of oxymethyl-modified coumarinic acid cyclic prodrugs of diastereomeric opioid peptides in biological media from various animal species including human.
Liederer BM; Borchardt RT
J Pharm Sci; 2005 Oct; 94(10):2198-206. PubMed ID: 16136552
[TBL] [Abstract][Full Text] [Related]
35. An in vivo assay for the analysis of the biological potency and structure-activity relationships of narcotics: serum testosterone depletion in the male rat.
Cicero TJ
J Pharmacol Exp Ther; 1977 Sep; 202(3):670-5. PubMed ID: 19620
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and antinociceptive activity of [D-Ala2]Leu-enkephalin derivatives conjugated with the adamantane moiety.
Kitagawa K; Mizobuchi N; Hama T; Hibi T; Konishi R; Futaki S
Chem Pharm Bull (Tokyo); 1997 Nov; 45(11):1782-7. PubMed ID: 9396154
[TBL] [Abstract][Full Text] [Related]
37. The synthesis, bioactivity and enzyme stability of D-Ala2, EPhe4, Leu5-enkephalins.
Kimura H; Stammer CH; Shimohigashi Y; Ren-Lin C; Stewart J
Biochem Biophys Res Commun; 1983 Aug; 115(1):112-5. PubMed ID: 6615520
[TBL] [Abstract][Full Text] [Related]
38. Leucine enkephalin analogues containing a conformationally restrained N-terminal amino acid residue.
Deeks T; Crooks PA; Waigh RD
J Pharm Sci; 1984 Apr; 73(4):457-60. PubMed ID: 6726628
[TBL] [Abstract][Full Text] [Related]
39. Analgesic activity of substance P in rats: tolerance and cross-tolerance with enkephalin.
Naranjo JR; Fernandez-Tome MP; Del Rio J
Eur J Pharmacol; 1984 Feb; 98(1):133-6. PubMed ID: 6201370
[TBL] [Abstract][Full Text] [Related]
40. Species differences in the relative analgesic potencies of some classical opiates and opioid peptides.
Székely JI; Miglécz E; Bajusz S
Psychopharmacology (Berl); 1984; 82(4):400-2. PubMed ID: 6328558
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
